Actavia Life Sciences, Inc.
RASP · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$96 | -$148 | -$58 | -$105 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $36 | $78 | $56 | $110 |
| Other Non-Cash | $24 | $23 | $9 | $5 |
| Operating Cash Flow | -$36 | -$47 | $7 | $10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $18 | -$9 | $66 | -$10 |
| Stock Issued | $0 | $0 | -$205,915 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $18 | -$9 | $66 | -$10 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18 | -$56 | $73 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19 | $75 | $2 | $2 |
| End Cash | $1 | $19 | $75 | $2 |
| Free Cash Flow | -$36 | -$47 | $7 | $10 |